Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Shi

Showing results (1351-1360 of 1,428) with videos related to

Pageof 143
Sort By:
Hepatology International|November 18, 2023
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancerAo Huang, De-Zhen Guo, Xuan Zhang, et al.
Annals of Translational Medicine|May 13, 2020
Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resectionWei-Feng Qu, Pei-Yun Zhou, Wei-Ren Liu, et al.
Cell Discovery|March 6, 2023
CD36<sup>+</sup> cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factorGui-Qi Zhu, Zheng Tang, Run Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.
Plos One|October 15, 2011
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantationJie Hu, Zheng Wang, Jia Fan, et al.
BMC Medicine|June 6, 2019
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinomaMeng-Xin Tian, Wei-Ren Liu, Han Wang, et al.
Acta Pharmacologica Sinica|May 1, 2021
Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsuleXiao-Fang Lan, Olajide E Olaleye, Jun-Lan Lu, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Immunometabolic remodeling of perivascular adipose tissue in murine lupus: implications for lupus vasculopathyLingling Liu, David Kim, Yong Zhang, et al.
Signal Transduction and Targeted Therapy|January 21, 2025
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8<sup>+</sup>T and tumor cellsGui-Qi Zhu, Zheng Tang, Tian-Hao Chu, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 16, 2006
[Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies]Fei Pei, Jie Zheng, Zi-fen Gao, et al.
Pageof 143

Showing results (1351-1360 of 1,428) with videos related to

Sort By:
Pageof 143
Hepatology International|November 18, 2023
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancerAo Huang, De-Zhen Guo, Xuan Zhang, et al.
Annals of Translational Medicine|May 13, 2020
Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resectionWei-Feng Qu, Pei-Yun Zhou, Wei-Ren Liu, et al.
Cell Discovery|March 6, 2023
CD36<sup>+</sup> cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factorGui-Qi Zhu, Zheng Tang, Run Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.
Plos One|October 15, 2011
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantationJie Hu, Zheng Wang, Jia Fan, et al.
BMC Medicine|June 6, 2019
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinomaMeng-Xin Tian, Wei-Ren Liu, Han Wang, et al.
Acta Pharmacologica Sinica|May 1, 2021
Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsuleXiao-Fang Lan, Olajide E Olaleye, Jun-Lan Lu, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Immunometabolic remodeling of perivascular adipose tissue in murine lupus: implications for lupus vasculopathyLingling Liu, David Kim, Yong Zhang, et al.
Signal Transduction and Targeted Therapy|January 21, 2025
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8<sup>+</sup>T and tumor cellsGui-Qi Zhu, Zheng Tang, Tian-Hao Chu, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 16, 2006
[Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies]Fei Pei, Jie Zheng, Zi-fen Gao, et al.
Pageof 143